Antimicrobial Peptides from Phages Fight Drug-Resistant Bacteria
Author Information
Author(s): Rothong Punnaphat, Leungtongkam Udomluk, Khongfak Supat, Homkaew Chanatinat, Samathi Sirorat, Tandhavanant Sarunporn, Ngoenkam Jatuporn, Vitta Apichat, Thanwisai Aunchalee, Sitthisak Sutthirat
Primary Institution: Naresuan University
Hypothesis
Can phage-encoded antimicrobial peptides effectively combat multidrug-resistant Acinetobacter baumannii when used in combination with colistin and outer membrane permeabilizing agents?
Conclusion
The study found that phage-encoded peptides PE04-1, PE04-1(NH2), and PE04-2 effectively inhibit multidrug-resistant A. baumannii and enhance survival rates in infection models.
Supporting Evidence
- Three peptides showed significant antimicrobial activity against multidrug-resistant A. baumannii.
- The peptides improved survival rates in G. mellonella models, exceeding 80% by day 10.
- The combination of peptides with colistin showed high inhibition percentages and low fractional inhibitory concentration indexes.
- The peptides did not affect the viability of human hepatoma cell lines at MIC levels.
- PE04-2 demonstrated the most potent inhibition of biofilm formation among the tested peptides.
Takeaway
Scientists created special proteins from viruses that can kill superbugs, and they work even better when combined with certain medicines.
Methodology
The study involved designing antimicrobial peptides from bacteriophages, testing their minimum inhibitory concentrations (MIC), and evaluating their synergistic effects with colistin and outer membrane permeabilizing agents.
Limitations
Different peptides exhibited varying levels of inhibition and may have unique mechanisms of action.
Participant Demographics
Bacterial strains included A. baumannii clinical isolates from tertiary hospitals in Thailand.
Statistical Information
P-Value
<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website